ADI is pleased to welcome both Her Majesty The Queen Sofía of Spain and Her Royal Highness Princess Muna Al Hussein of Jordan to ADI’s 36th International Conference
AD-RIDDLE, funded by the Innovative Health Initiative, a European Union public privative partnership, brings together academics, healthcare providers, pharmaceutical companies, regulatory bodies to develop tools and resources for healthcare providers.
In this press release, it is revealed that the World Alzheimer Report 2022 finds as many as 85 percent of people with dementia could be missing out on post-diagnosis care.
In this exercept from the essay 'The impact of caregiving in LGBTQ+ communities', from the World Alzheimer Report 2022, Julien Rougerie outlines the challenges of caregiving faced by the LGBTQ+ community.
In this exercept from the essay 'Living to the best of one's ability', from the World Alzheimer Report 2022, Keith Oliver shares how the support of others has helped him to navigate life since his diagnosis 11 years ago.
In this blog, Shamayne Leelawati shares how her caring journey for her father changed after COVID-19 and how it inspired her to change the narrative around post-diagnostic care.
ADI, alongside Newcastle University and the London School of Economics, is submitting an application to the WHO Expert Committee on the inclusion of anti-dementia medication and needs to hear from clinicians everywhere.
As a part of the STRiDE project, the STRiDE Kenya team recently developed an anti-stigma toolkit and 'train the trainers' manual which aims to change the public perception around dementia in Kenya.
The project, launching 1 September, will aim to raise funds for ADI through the sale of a collection of photographs in the form of NFTs.
DY Suharya, ADI Regional director for Asia Pacific, will lead on a Values 20 (V20) work stream in preparation for the G20 summit, taking place on 15-16 November 2022.